Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Anastasia Aleksandrovna Oreshkina has a total of 21 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Complex multifactorial prediction model for life-threatening ventricular arrhythmias in patients with myocardial infarction

    by E. V. Averyanova, A. A. Tonkoglaz, A. A. Chernova, N. A. Donetskaya, V. E. Oleynikov

    Комплексная модель многофакторного прогнозирования жизнеугрожающих желудочковых нарушений ритма у больных инфарктом миокарда


  • Advantages of long-term telemetric electrocardiogram monitoring in patients with myocardial infarction

    by V.E. Oleynikov, A.N. Rogoza, E.V. Averyanova, A.A. Tonkoglaz

    The latest technologies of long-term ECG registration improve detection of rhythm and conduction disturbances, as well as comprehensively assess autonomic regulation of heart rhythm. OBJECTIVE To identify the advantages of long-term telemetric ECG monitoring for 72 hours (TMM72 ECG) for recording arrhythmic events, episodes of conduction disturbances, as well as for evaluating the parameters of electrical instability in patients with myocardial infarction (MI). MATERIAL AND METHODS The study included 114 ICU patients aged 58 (52; 62) years with MI. TMM72 Nehb 3-lead (A, D, I) ECG was performed using the ASTROCARD®-TELEMETRY telemetry complex for 72 hours from the 4th day after MI. We assessed frequent and paired supraventricular premature contractions, supraventricular tachycardia (SVT), ventricular arrhythmias Lown—Wolf grade ≥3, sinoatrial and atrioventricular (SA- and AV-) blockages, paroxysms of atrial fibrillation. Chronotropic load (CL), heart rate variability (HRV), heart rate turbulence (HRT), microvolt alternation of T wave (MAT), late ventricular potentials (LVPs), and QT interval variance were evaluated. The transmitted data were analyzed at the end of each day of monitoring, and then we estimated certain time intervals (24, 48 and 72 hours). RESULTS The number of patients with frequent supraventricular premature contractions increased by 13.1% (p=0.04), paired supraventricular premature contractions by 22.7% (p=0.001) and SVT by 21% (p=0.003) compared to standard 24-hour ECG monitoring. Ventricular premature contractions Lown—Wolf grade ≥3 were registered in 65 patients (57%) that is 1.6 times higher compared to standard 24-hour ECG monitoring (p=0.031). SA- and AV- blockages grade 2 were 2 times more common (p=0.044). Impaired HRT was detected in 32.5% and 15.8% of cases, respectively (p=0.06). The number of patients with MAT increased by 14.9% (p=0.021) after 72 hours of continuous monitoring. CL Sa demonstrated total decrease from 1.07 (0.26; 3.8) on the first day to 0.94 (0.26;4.2) (p=0.022) by the end of TMM72 ECG. HRV parameters positively changed by the end of monitoring: TotP — by 46% (p=0.001), ULfP — by 47% (p=0.001), LfP — by 43% (p=0.001), HfP — by 37% (p=0.001), L/H increased by 49% (p=0.001). CONCLUSION TMM72 ECG significantly improves detection of clinically significant rhythm and conduction disorders. This method is valuable for comprehensive assessment of autonomic regulation of heart rhythm and markers of myocardial electrical instability in early period after MI.


  • Open Access

    Combined lipid lowering therapy, including ezetimibe, in the post-infarction period

    by V. E. Oleynikov, L. I. Salyamova, A. A. Chernova, A. A. Tonkoglaz, O. D. Vershinina, I. A. Babkina, N. S. Plaksin

    Aim. To study the effect of 48-week therapy with atorvastatin and ezetimibe on laboratory parameters, structural and functional arterial characteristics and heart failure markers in the post-infarction period.Material and methods. A total of 87 patients with acute myocardial infarction were included. In the first 24 hours, atorvastatin 80 mg/day was prescribed. During hospitalization, after 5-6, 24, 48 weeks, clinical and paraclinical examinations were performed. In the level of low-density lipoprotein cholesterol (LDL-C) >1,4 mmol/l and the decrease Results. Eighty participants (93%) completed the study. Patients were divided into following groups: group 1 (n=32) — atorvastatin monotherapy; group 2 (n=49) — ezetimibe and atorvastatin therapy. In group 1, LDL-C decreased after 48 weeks by 53% (pConclusion. The results rationale adding ezetimibe to statins in very high-risk patients due to the most pronounced lipid lowering effect, improvement of the structural and functional properties of the common carotid arteries, endothelial function and clinical and laboratory heart failure markers.


  • Predictors of recurrent cardiovascular events in patients with a single-vessel coronary artery disease after ST-segment elevation myocardial infarction

    by V. E. Oleynikov, E. V. Averyanova, A. A. Tonkoglaz, M. V. Lukyanova

    Aim. To determine the predictors of recurrent cardiovascular events in patients after ST-segment elevation myocardial infarction (STEMI) and hemodynamicallysignificant stenosis only in the infarct-related coronary artery.Material and methods. The present study involved 151 patients with STEMI. The mean age of patients was 51 (95% confidence interval (CI), 41–61 years) years. One of the inclusion criteria of patients was significant stenosis exclusively in the infarct-related artery. All patients underwent a 24-hour Holter electrocardiography (ECG) monitoring with the analysis of heart rate turbulence (HRT), heart rate variability (HRV), ventricular late potentials and chronotropic load; two-dimensional (2D) echocardiography with the analysis of volumetric parameters and left ventricular ejection fraction; determination of brain natriuretic peptide (BNP). The follow-up duration was 144 weeks. Repeated cardiovascular events (acute heart failure, revascularization, repeated myocardial infarction, cardiovascular death) were analyzed as endpoints. Two groups of patients were identified depending on the recurrent event endpoints: “RE” group — 26 patients (17.2%) with registered recurrent cardiac events, and “ST” group — 125 patients (82.8%) without cardiovascular events in stable post-infarction period.Results. Initial BNP values were lower in the “ST” group (p48=0.0035, p96=0.004, p144=0.001). The intergroup differences demonstrate a higher concentration of BNP levels in the “RE” group both initially (p=0,001) and at the 96th week (p=0,04). Left ventricular ejection fraction was higher in the “ST” group (p=0,001) both initially and at the 144th week in contrast to the “RE” group: 48,9% (44,7-53,2) vs 44,2% (38,5-49,9) (p=0,009). Pathological HRT was also significantly higher in the “RE” group both initially (p=0,003) and by the 96th week of the follow-up (p=0,007), while HRV demonstrated low initial values with a slow tendency to restoration. There were following risk factors for recurrent cardiovascular events in patients in the post-infarction period: weight — relative risk (RR), 1.21 (95% CI, 1,01-1,46) (p=0,03); body mass index — RR, 0,56 (95% CI, 0,325-0,96) (p=0,046); chronotropic load — RR, 1,03 (95% CI, 1,02-1,12) (p=0,04); BNP — RR, 1,012 (95% CI, 1,003-1,08) (p=0,01); left ventricular end-systolic dimension (ESD) — RR, 1,04 (95% CI, 1,01-1,13) (p=0,36).Conclusion. There were following independent predictors of recurrent cardiovascular events in patients after STEMI: weight, body mass index, chronotropic load, BNP and ESD.


  • Parameters Of Myocardial Electrical Instability In Patients After Myocardial Infarction Comorbid With A Novel Coronavirus Infection (COVID-19)

    by Anastasia A. Tonkoglaz, Elena V. Averyanova, Yulia A. Barmenkova, Maryam A. Yangurazova, Marina V. Lukyanova, Valentin E. Oleynikov

    Objective — This article aims to assess parameters of myocardial electrical instability and arrhythmic events in patients after myocardial infarction (MI), with and without ST-segment elevation, comorbid/noncomorbid with a novel coronavirus infection (COVID-19) using a long-term electrocardiographic (ECG) monitoring. Methods — The study included 64 subjects: 25 (39%) patients with MI comorbid with COVID-19 (MI+C group) and 39 (61%) patients with MI noncomorbid with a novel coronavirus infection (MI group). The mean age of patients was 54.3±6.8 years. A long-term ECG monitoring for 97.4 (95% CI 77.9-115.2) hours was performed with Astrocard®-Telemetry system (Meditek JSC, Russia), starting from the 4th day of MI. Rhythm and conduction disorders, along with ischemic episodes were recorded; an analysis of ventricular late potentials, heart rate turbulence, and QT dispersion was carried out. Results — There were no differences in the frequency of delayed afterdepolarizations in MI and MI+C groups: 15-28% and 18-33% of patients, respectively. An analysis of turbulence parameters did not reveal statistically significant differences between the groups. Such arrhythmic events as frequent supraventricular extrasystole and life-threatening arrhythmias (ventricular extrasystole of grade 4A and higher sensu B. Lown and M. Wolf) were recorded significantly more often in the MI+C group than in the MI group: 48% vs. 20.5% (p=0.021) and 24% vs. 5.1% (p=0.026), respectively. Conclusion — The novel coronavirus infection (COVID-19) exacerbates myocardial electrophysiological heterogeneity in the acute cardiovascular event and is associated with an increase in clinically significant arrhythmic events.

  • Open Access

    Capabilities of long-term ECG monitoring in patients with myocardial infarction: the longer, the better?

    by V. E. Oleynikov, E. V. Averyanova, A. A. Oreshkina, Yu. A. Barmenkova, A. V. Kulyutsin

    Background. In modern cardiology, 24-hour electrocardiogram (ECG) monitoring has a high diagnostic value, but this method has a number of disadvantages in detecting episodes of unstable life-threatening arrhythmias. An increase in ECG monitoring duration allows expanding the possibilities of diagnosing life-threatening arrhythmias.Objective. To study the possibilities of long-term ECG monitoring (48–120 hours) in the detection of life-threatening arrhythmic events and parameters of myocardial electrical instability in patients with ST-segment elevation myocardial infarction (STEMI).Design and methods. The study included 71 STEMI patients. All patients from the 4th day of STEMI underwent multi-day ECG monitoring in 3 leads using a telemetric ECG recording complex with an average recording duration of 90.4 ± 30.2 hours. The analysis of episodes of myocardial ischemia, rhythm and conduction disturbances, turbulence and heart rate variability, late ventricular potentials and dispersion of the QT interval within 5 days was carried out.Results. Long-term monitoring allowed detecting high-grade ventricular extrasystoles. Analysis of episodes of myocardial ischemia in the postinfarction period revealed significant differences in the data of 120h-ECG monitoring in comparison with 24h-ECG. Multiday ECG monitoring made it possible to detect dysfunction of the autonomic regulation of cardiac activity in patients 2 times more often.Conclusion. A comprehensive assessment of the possibilities of multi-day ECG monitoring is a promising direction in predicting severe arrhythmias in patients in the postinfarction period.


  • Open Access

    A Multivariate Model to Predict Chronic Heart Failure after Acute ST-Segment Elevation Myocardial Infarction: Preliminary Study

    by Valentin Elievich Oleynikov, Elena Vladimirovna Averyanova, Anastasia Aleksandrovna Oreshkina, Nadezhda Valerievna Burko, Yulia Andreevna Barmenkova, Alena Vladimirovna Golubeva, Vera Aleksandrovna Galimskaya

    A multivariate model for predicting the risk of decompensated chronic heart failure (CHF) within 48 weeks after ST-segment elevation myocardial infarction (STEMI) has been developed and tested. Methods. The study included 173 patients with acute STEMI aged 51.4 (95% confidence interval (CI): 42–61) years. Two-dimensional (2D) speckle-tracking echocardiography (STE) has been performed on the 7th–9th days, and at the 12th, 24th, and 48th weeks after the index event with the analysis of volumetric parameters and values for global longitudinal strain (GLS), global circumferential strain (GCS), and global radial strain (GRS). A 24-h ECG monitoring (24 h ECG) of the electrocardiogram (ECG) to assess heart rate turbulence (HRT) has been performed on the 7th–9th days of STEMI. The study involved two stages of implementation. At the first stage, a multivariate model to assess the risk of CHF progression within 48 weeks after STEMI has been built on the basis of examination and follow-up data for 113 patients (group M). At the second stage, the performance of the model has been assessed based on a 48-week follow-up of 60 patients (group T). Results. A multivariate regression model for CHF progression in STEMI patients has been created based on the results of the first stage. It included the following parameters: HRT, left ventricular (LV) end-systolic dimension (ESD), and GLS. The contribution of each factor for the relative risk (RR) of decompensated CHF has been found: 3.92 (95% CI: 1.66–9.25) (p = 0.0018) for HRT; 1.04 (95% CI: 1.015–1.07) (p = 0.0027) for ESD; 0.9 (95% CI: 0.815–0.98) (p = 0.028) for GLS. The diagnostic efficiency of the proposed model has been evaluated at the second stage. It appeared to have a high specificity of 83.3%, a sensitivity of 95.8%, and a diagnostic accuracy of 93.3%. Conclusion. The developed model for predicting CHF progression within 48 weeks after STEMI has a high diagnostic efficiency and can be used in early stages of myocardial infarction to stratify the risk of patients.


  • THE INFLUENCE OF THE ENDOVASCULAR INTERVENTION TIMING ON THE POST-INFARCTION PERIOD

    by Penza State University, M. V. Luk'YAnova, E. V. Dushina, Yu. A. Barmenkova, A. A. Oreshkina

    Article 4219. Пензенский государственный университет